Status:
COMPLETED
Ectopic Lipid Deposition and Insulin Resistance in After Treatment of Acromegaly
Lead Sponsor:
Massachusetts General Hospital
Collaborating Sponsors:
Ipsen
Conditions:
Acromegaly
Eligibility:
All Genders
18-75 years
Brief Summary
This study investigates fat distribution in people with acromegaly. The investigator is also investigating the change of fat distribution before and after treatment of acromegaly. The investigator wil...
Eligibility Criteria
Inclusion
- Ages 18 - 75 yr (both groups)
- Study subjects with active acromegaly
- Healthy controls
Exclusion
- Serum creatinine or alanine aminotransferase (ALT) \> 2 times the upper limit of normal, metastatic cancer.
- Controls will be receiving no medications and have no chronic diseases, including cancer, hypertension or diabetes mellitus.
- Contraindications to MRI imaging (both groups) like those with certain metal implants, surgical clips or pacemakers.
- Pregnant women
Key Trial Info
Start Date :
April 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 30 2016
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT01819883
Start Date
April 1 2013
End Date
March 30 2016
Last Update
June 20 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Massachusetts General Hospital
Boston, Massachusetts, United States, 02114